Bioengineered Organ Implant Developer HART Reviews Progress and Q4 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Harvard Apparatus (HART) Reports Q4 Loss of $0.17/Share
March 17, 2016 4:23 PM EDTHarvard Apparatus (NASDAQ: HART) reported Q4 EPS of ($0.17), versus ($0.36) reported last year. Revenue for the quarter came in at $8 thousand, versus $1.6 million reported last year.
For earnings history and earnings-related data on Harvard Apparatus (HART) click here.
... More